To provide a comprehensive suite of developmental and reproductive toxicology (DART) studies for the progression of pharmaceuticals and biopharmaceuticals, Creative Biolabs offers DART solutions including male and female fertility, developmental toxicity studies to evaluate the potential safety effects of the candidate drug or therapy on the full spectrum of development and reproduction.
Creative Biolabs offers one-stop DART services, ranging from program planning and individual study design to study implementation, in full compliance with international regulatory standards, including ICH and OECD. The scope of our services includes pharmaceuticals (small and large molecules), and biopharmaceuticals (cellular and gene therapy, vaccines).
We are dedicated to providing studies about male/female fertility and developmental toxicity, including embryo-fetal development, pre/postnatal development, and multigenerational development, to evaluate the potential safety risks associated with novel therapies on the entire development and reproductive spectrum.
Animal models: a full range of rodent and nonrodent species are
available to fit your program.
Routes of administration: dose routes ranging from dermal infusion
to intravenous infusion.
Creative Biolabs offers comprehensive, state-of-the-art DART services to help our clients make smarter decisions faster. We are dedicated to pioneering advances in DART studies to move your program into IND approval. Please contact us for more detailed information.
For Research Use Only | Not For Clinical Use